6160.HK BEONE MEDICINES | KYG1146Y1017
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 7.454.306.940 | 6.495.005.420 | 14.77% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 0,76 | 0,50 | 52.72% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 11 | 10 | 10.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |